Published • loading... • Updated
Syndax Pharmaceuticals (NASDAQ:SNDX) Announces Quarterly Earnings Results
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Syndax Pharmaceuticals (NASDAQ:SNDX) Announces Quarterly Earnings Results
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.06), FiscalAI reports. The company had revenue of $83.30 million during the quarter, compared to analysts’ expectations of $81.80 million. Syndax Pharmaceuticals had a negative return […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
